Bank of New York Mellon Corp - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 139 filers reported holding ENDOLOGIX INC in Q4 2013. The put-call ratio across all filers is 733.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$237,000
-65.4%
331,604
-7.4%
0.00%
Q3 2018$684,000
-66.3%
358,185
-0.1%
0.00%
-100.0%
Q2 2018$2,030,000
+31.7%
358,670
-1.6%
0.00%
Q1 2018$1,541,000
-19.6%
364,478
+1.8%
0.00%
-100.0%
Q4 2017$1,916,000
+20.4%
358,079
+0.4%
0.00%
Q3 2017$1,591,000
-60.3%
356,802
-56.7%
0.00%
-100.0%
Q2 2017$4,009,000
-34.1%
824,928
-1.8%
0.00%
-50.0%
Q1 2017$6,081,000
+21.3%
839,948
-4.2%
0.00%
+100.0%
Q4 2016$5,014,000
-48.6%
876,405
+15.0%
0.00%
-66.7%
Q3 2016$9,752,000
+67.7%
761,904
+63.2%
0.00%
+50.0%
Q2 2016$5,815,000
+108.9%
466,721
+40.1%
0.00%
+100.0%
Q1 2016$2,784,000
-4.3%
333,045
+13.4%
0.00%0.0%
Q4 2015$2,908,000
-84.7%
293,721
-81.0%
0.00%
-83.3%
Q3 2015$18,964,000
-25.1%
1,546,806
-6.2%
0.01%
-14.3%
Q2 2015$25,306,000
-16.5%
1,649,704
-7.1%
0.01%
-12.5%
Q1 2015$30,314,000
-28.9%
1,775,895
-36.3%
0.01%
-27.3%
Q4 2014$42,621,000
+71.9%
2,787,572
+19.2%
0.01%
+57.1%
Q3 2014$24,799,000
-58.6%
2,339,526
-40.6%
0.01%
-12.5%
Q2 2014$59,948,000
+224.8%
3,941,368
+174.8%
0.01%
+60.0%
Q1 2014$18,458,000
+236.6%
1,434,154
+356.2%
0.01%
+150.0%
Q4 2013$5,484,000
-44.2%
314,400
-48.4%
0.00%
+100.0%
Q3 2013$9,828,000
+149.6%
609,004
+105.4%
0.00%0.0%
Q2 2013$3,937,000296,4560.00%
Other shareholders
ENDOLOGIX INC shareholders Q4 2013
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 1,165,428$35,549,00017.87%
Iguana Healthcare Management, LLC 160,000$2,790,0001.59%
Elk Creek Partners, LLC 112,839$1,968,0001.42%
Tygh Capital Management, Inc. 338,424$5,902,0001.24%
NEXT CENTURY GROWTH INVESTORS LLC 2,471,336$43,100,0001.19%
First Light Asset Management, LLC 75,738$1,321,0001.12%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 273,954$4,778,0001.07%
WASHINGTON CAPITAL MANAGEMENT, INC 195,316$3,406,0000.82%
PALISADE CAPITAL MANAGEMENT, LP 1,605,163$27,994,0000.73%
ArrowMark Colorado Holdings LLC 1,286,044$22,429,0000.70%
View complete list of ENDOLOGIX INC shareholders